Hyperion Therapeutics, Inc agreed to be sold to Horizon Pharma, announced on Mar 30, 2015.
8-KCenterview Partnersfirm and Houlihan Lokey Capitalfirm advised the seller.
8-KCitigroup Global Marketsfirm, TD Securities (USA)firm and Jefferiesfirm advised the buyer.
8-KThe filing puts the value at $1.1B.
8-KCenterview Partnersfirm also worked on Maplebear Incdeal, on Oct 29, 2026.
8-K
At a glance
Who was on each side
Seller's adviserCenterview Partners
Seller's adviserHoulihan Lokey Capital
BuyerHorizon Pharma
Buyer's adviserCitigroup Global Markets
Buyer's adviserTD Securities (USA)
Buyer's adviserJefferies
Parties
first 2 of 6
| Party | Role | Source |
|---|---|---|
| Horizon Pharma | Buyer | 8-K |
| Centerview Partners | Seller's adviser | 8-K |
4 more parties
Sign up free to see the first 5, or become a member to see all 6.
Value
| Kind | Amount | Basis | Source |
|---|---|---|---|
| Price | $1.1B | equity value | 8-K |
More deals
first 2 of 20
| Date | Deal | Firms | Source |
|---|---|---|---|
| Oct 29, 2026 | ADT Inc · Sale | Thrive Capital, Citigroup Global Markets | 8-K |
| Oct 29, 2026 | Maplebear Inc · Sale | Goldman Sachs & Co., Centerview Partners | 8-K |
18 more deals
Deals with Centerview Partners, Houlihan Lokey Capital and 3 more firms.
Sign up free to see the first 5, or become a member to see all 20.